Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer

This publication has 30 references indexed in Scilit:

• Association of Grb7 with Phosphoinositides and Its Role in the Regulation of Cell Migration
  Journal of Biological Chemistry, 2002
• Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
  Journal of Clinical Oncology, 2002
• and choice of adjuvant chemotherapy in breast cancer
  Seminars in Oncology, 2001
• Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays
  Nature Genetics, 1999
• The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy
  Seminars in Cancer Biology, 1999
• Should Selection of Adjuvant Chemotherapy for Patients With Breast Cancer Be Based on erbB-2 Status?
  JNCI Journal of the National Cancer Institute, 1998
• Identification of Four Novel Human Genes Amplified and Overexpressed in Breast Carcinoma and Localized to the q11-q21.3 Region of Chromosome 17
  Genomics, 1995
• Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
  European Journal Of Cancer, 1993
• Molecular dissection of mammalian gene amplification: New mechanistic insights revealed by analyses of very early events
  Mutation Research/Reviews in Genetic Toxicology, 1992
• Recent progress in understanding mechanisms of mammalian DNA amplification
  Cell, 1989